Decipher Labs Peer Comparison

Snapshot Summary

Decipher Labs Ltd. is underperforming significantly compared to its peers in the Pharmaceuticals & Drugs industry, with negative growth, profitability, and efficiency metrics. The sector shows a mix of strong performers and financially stable companies, making Decipher Labs a clear outlier on the downside.

• Decipher Labs shows negative revenue growth and profitability metrics, with a PE ratio of -23.81 indicating significant losses.
• Sun Pharmaceutical Industries and Dr. Reddy's Laboratories are standout performers with high ROE, profitability, and positive growth.
• Financially weak companies include Decipher Labs, which has low margins and negative earnings metrics.

• Sun Pharmaceutical Industries Ltd.: Highest revenue growth YoY at 8.42% and strong profitability with a ROE of 16.13%.
• Dr. Reddy's Laboratories Ltd.: Robust profitability metrics with a PE of 15.50 and high ROE of 21.76%.

Stock	CMP	Market Cap	P/E	ROE (%)	ROCE (%)	Debt/Equity
Decipher Labs Ltd.	₹9.73	₹9.83Cr	-1.04	-7.44%	-4.24%	-
SUNPHARMA	₹1,706.40	₹4,09,626.46Cr	39.49	16.16%	19.89%	0.03
DIVISLAB	₹6,804.00	₹1,80,668.62Cr	78.35	15.35%	20.45%	0.00
CIPLA	₹1,511.50	₹1,22,102.70Cr	22.44	16.63%	22.77%	0.01
TORNTPHARM	₹3,628.30	₹1,20,456.12Cr	60.17	26.46%	27.32%	0.40
DRREDDY	₹1,196.00	₹99,965.86Cr	17.32	18.61%	23.25%	0.14
ZYDUSLIFE	₹981.05	₹98,057.50Cr	21.45	21.08%	26.06%	0.13

Explore

Watchlists

Command Palette

Decipher Labs Peer Comparison

Snapshot Summary